For consideration, please submit your resume via email:
Abilita Bio’s goal is to become the leader in discovering, developing and partnering transformative membrane protein-targeted therapeutics. The company is privately held and is an innovation-driven startup biotech company focused on leveraging our Enabled Membrane Proteins (EMPs™) technology platform to enable discovery and development of drugs targeting challenging membrane proteins, including G Protein-Coupled Receptors (GPCRs), transporters and ion channels.
– We have already established several research collaborations with global pharmaceutical companies, and will continue to execute pharma deals around antibody, small molecule and structure-based discovery efforts;
– We are propelling our internal pipeline efforts around voltage-gated sodium channels and GPCR-targeted therapeutic antibody discovery;
– We are expanding our technology platform capabilities toward new target families and novel approaches such as conformational-biased EMPs™ and stabilized protein complexes.